Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum
Open Access
- 22 March 2024
- journal article
- review article
- Published by Springer Nature in Chinese Medicine
- Vol. 19 (1) , 1-11
Abstract
Ganoderma lucidum is a precious fungus, particularly valued for its dual use as both medicine and food. Ganoderic acids (GAs), the distinctive triterpenoids found in the Ganoderma genus, exhibit a wide range of pharmacological activities. However, the limited resources of GAs restrict their clinic usage and drug discovery. In this review, we presented a comprehensive summary focusing on the diverse structures and pharmacological activity of GAs in G. lucidum. Additionally, we discussed the latest advancements in the elucidation of GA biosynthesis, as well as the progress in heterosynthesis and liquid fermentation methods aimed at further increasing GA production. Furthermore, we summarized the omics data, genetic transformation system, and cultivation techniques of G. lucidum, described as medicinal model fungi. The understanding of Ganoderic acids chemodiversity and biosynthesis in medicinal model fungi Ganoderma lucidum will provide important insights into the exploration and utilization of natural products in medicinal fungi.Keywords
Funding Information
- The National Key R&D Program of China (2023YFC3504800)
- CAMS Innovation Fund for Medical Sciences (2021-1-I2M-022)
- Zhejiang Science and Technology Major Program on Agricultural New Variety Breeding (2021C02073)
This publication has 79 references indexed in Scilit:
- Classification, Biological Characteristics and Cultivations of Ganoderma2019
- Ganoderic acid A against cyclophosphamide‐induced hepatic toxicity in miceJournal of Biochemical and Molecular Toxicology, 2018
- Biosynthesis of a ganoderic acid in Saccharomyces cerevisiae by expressing a cytochrome P450 gene from Ganoderma lucidumBiotechnology and Bioengineering, 2018
- Induction of ganoderic acid biosynthesis by Mn2+ in static liquid cultivation of Ganoderma lucidumBiotechnology and Bioengineering, 2014
- Enhanced recovery of antitumor ganoderic acid T from Ganoderma lucidum mycelia by novel chemical conversion strategyBiotechnology and Bioengineering, 2011
- Improvement of ganoderic acid and Ganoderma polysaccharide biosynthesis by Ganoderma lucidum fermentation under the inducement of Cu2+Biotechnology Progress, 2009
- Crystal structure of LZ‐8 from the medicinal fungus Ganoderma lucidiumProteins: Structure, Function, and Bioinformatics, 2008
- A novel three‐stage light irradiation strategy in the submerged fermentation of medicinal Mushroom Ganoderma lucidum for the efficient production of ganoderic acid and Ganoderma polysaccharidesBiotechnology Progress, 2008
- Natural products of the medicinal fungus Ganoderma lucidum: Occurrence, biological activities, and pharmacological functionsThe Chemical Record, 2003
- Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes from Ganoderma lucidum (FR.) KARST.Helvetica Chimica Acta, 1982